CHI3L1 and cancer: Elevated levels of YKL-40 have been observed in numerous chronic inflammatory and fibrotic diseases characterized by extracellular matrix (ECM) dysregulation, such as idiopathic pulmonary fibrosis [13,26], asthma [27,28], and cancer [29,30,31].